Miguel Lança

BRCA1 VUS: A functional analysis to differentiate pathogenic from benign variants identified in clinical diagnostic panels for breast cancer

J. Pereira-Leal, O. Monteiro Gil, J. Cardoso, 2023, Molecular medicine reports.